
A dengue virus vaccine candidate has passed an important milestone, with promising results in animal model testing providing hope to the 390 million people infected every year.
The University of Queensland-developed vaccine candidate, applied to the skin via the high-density microarray patch (HD-MAP), has produced a protective immune response in dengue-infected mice.
UQ PhD candidate Jovin Choo said the result could lead to a readily administered vaccine that could help halt the devastation of dengue fever globally.
“Dengue is the most significant mosquito-borne viral disease in the world’s tropical zone, infecting 390 million and killing 25,000 annually, resulting in annual estimated economic cost of $8.9 billion,” Ms Choo said.
“While a dengue vaccine technically already exists, it’s only licensed to be used in certain countries where Dengue virus is endemic – and with restricted use.
“So to properly fight this terrible disease, we’ve engineered a vaccine candidate based on a platform technology that uses an Australian insect virus called Binjari virus.”
UQ researchers merged the Binjari and dengue viruses making what’s known as a chimeric virus – an artificial virus – to build the basis of the vaccine which has resulted in some great benefits.
“For instance, the particles exactly mimic the surface of their dengue counterpart, which induces a strong, authentic and protective immune response,” Ms Choo said.
“Also, it allows us to very easily manufacture high yields of the vaccine candidate in mosquito cell culture.
“And it only grows in insect cells, and not mammalian cells, making it extremely safe.”
UQ’s Dr David Muller, one of the senior authors of the research, said another advantage was that the candidate could offer potent antibody responses when delivered via the UQ-developed, Vaxxas Pty Ltd commercialised, HD-MAP system.
“Using the microarray patch, we’re able to employ needle-free delivery of the vaccine to the immune cell-rich layers of the skin with just a click,” he said.
“This targeted delivery allows us to achieve potent neutralising antibody responses using a fraction of a typical dose delivered by injection.
“The ease of administration, coupled with lower dose amounts means that the patch could provide both an efficient and inexpensive vaccination option.”
UQ’s Dr Jody Hobson-Peters said this was only the start with the research team looking to apply these techniques more widely.
“There are four variations of dengue that are closely related, all of which can cause severe disease,” Dr Peters said.
“So we’re now expanding our ongoing pre-clinical studies to all four of these forms of dengue virus.
“And we’re also looking to adapt this technology to other viruses, like Zika virus, West Nile virus and Japanese encephalitis virus.
“These are daunting diseases but cheap, easy and accessible vaccinations for them might one day be just a click away.”
Original Article: Jab-free dengue immunity could be just a click away
More from: University of Queensland
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
High-density microarray patch
- Typhoid Antibody Testing Market Size, Outlook: Exploring the 6.55% CAGR and USD 12.36 Billion Projection by 2030
Zion Market Research has published a new research report titled "Typhoid Antibody Testing Market By End-User (Hospitals, Serological Testing Centers, Clinics, Diagnostic ...
- Needle-Free Vaccine Patch Company Opens Manufacturing Facility
The 60,000 sq ft facility will support the production of millions of Vaxxas’ high density microarray patches (HD-MAPs) per year for use in future late-stage clinical trials and commercial vaccine ...
- Taking the Needle out of Vaccine Delivery
A needle-free COVID-19 vaccine candidate delivered using a high-density microarray patch (HD-MAP) is showing promise in a phase I human trial, according to Brisbane, Australia-based Vaxxas. The core ...
- MammaPrint™ 70-gene Signature: Another Milestone in Personalized Medical Care for Breast Cancer Patients
The TargetPrint assay determines the ER, PR and HER2 mRNA levels using eight subarrays on Agendia's new High-Density Microarray Chip. The TargetPrint assay has been validated against FDA-approved ...
- SK bioscience inks deal with Australian firm to develop patch-type typhoid vaccine
which will develop a new type of vaccine-delivery device using its high-density microarray patch (HD-MAP) platform technology based on the SKYTyphoid antigen. Vaxxas' HD-MAP delivers the vaccine ...
Go deeper with Google Headlines on:
High-density microarray patch
[google_news title=”” keyword=”high-density microarray patch” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
HD-MAP
- The Little Paris Kitchen: Cooking With Rachel Khoo CC HD G
Passionate, internationally-influenced ‘culinary creative’ Rachel Khoo believes that delicious French food is no longer the preserve of fancy Michelin starred restaurants. For the last year, this ...
- Looking for a New Headlamp? These Are the Ones Worth Buying for Setting Up Camp, Night Runs, and More
Whether you’re in the backcountry or under the kitchen sink, headlamps can bring some much-needed illumination.
- 7 Ways To Upgrade Your Character In The Legend of Nayuta: Boundless Trails
The one unique thing about leveling up and the overall design of The Legend of Nayuta: Boundless Trails is that the game is divided up into stages like in an action game. Players can go into a stage, ...
- MDC requests residents help in reporting hemorrhagic disease in deer
Reports of the disease help MDC biologists determine the impacts of the disease on deer numbers in specific areas. Residents can report suspected cases of HD to their local MDC office, a conservation ...
- Needle-Free Vaccine Patch Company Opens Manufacturing Facility
The 60,000 sq ft facility will support the production of millions of Vaxxas’ high density microarray patches (HD-MAPs) per year for use in future late-stage clinical trials and commercial vaccine ...
Go deeper with Google Headlines on:
HD-MAP
[google_news title=”” keyword=”HD-MAP” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]